MyAverix Finance
ST · Healthcare
Vicore Pharma Holding AB (publ) (VICO)
Biotechnology
Vicore Pharma Holding AB (publ) (VICO) is listed on ST in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported market cap is $3.36B, P/E ratio is 25.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for VICO
Vicore Pharma Holding AB (publ) (VICO) — FAQ
What is Vicore Pharma Holding AB (publ)'s market cap?
Vicore Pharma Holding AB (publ) (VICO) has a reported market cap of $3.36B (data as of 2026-05-24).
What is VICO's P/E ratio?
The price-to-earnings (P/E) ratio for Vicore Pharma Holding AB (publ) (VICO) is 25.00 (data as of 2026-05-24).
Does Vicore Pharma Holding AB (publ) pay a dividend?
Dividend yield is not available in the current snapshot for Vicore Pharma Holding AB (publ) (VICO). Check the MyAverix Finance app for the latest dividend data.
What sector is Vicore Pharma Holding AB (publ) in?
Vicore Pharma Holding AB (publ) (VICO) is classified in the Healthcare sector (Biotechnology industry).
What exchange is VICO listed on?
VICO is listed on ST.
What is Vicore Pharma Holding AB (publ)'s net margin?
Vicore Pharma Holding AB (publ) (VICO) reports a net margin of 0.0% (data as of 2026-05-24).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.